Summary
This 8-K/A filing from Eli Lilly and Company serves as an amendment to a previous 8-K report detailing the results of their 2017 Annual Meeting of Stockholders. The primary purpose of this amendment is to formally disclose the company's decision regarding the frequency of future "say on pay" advisory votes. Investors are informed that Eli Lilly will continue to hold these advisory votes on an annual basis.
Key Highlights
- 1Eli Lilly and Company (LLY) filed an 8-K/A on June 20, 2017, amending a prior filing.
- 2The amendment's sole purpose is to disclose the frequency of future 'say on pay' votes.
- 3The 2017 Annual Meeting of Stockholders included an advisory vote on the frequency of 'say on pay' proposals.
- 4A significant majority of shares voted for an annual 'say on pay' vote (767,754,104 votes).
- 5The Board of Directors has decided to hold future 'say on pay' votes on an annual basis.
- 6The next advisory vote on the frequency of 'say on pay' votes is required no later than the 2023 Annual Meeting of Shareholders.